We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
-3.77%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$2.97B
AUM Growth
-$162M
Cap. Flow
+$11.8M
Cap. Flow %
0.4%
Top 10 Hldgs %
30.79%
Holding
836
New
124
Increased
242
Reduced
227
Closed
121
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSS icon
701
One Stop Systems
OSS
$309M
$68K ﹤0.01%
+17,774
New +$73.9K
SAN icon
702
Banco Santander
SAN
$194B
$66K ﹤0.01%
19,396
RNTX
703
Rein Therapeutics
RNTX
$67.7M
$66K ﹤0.01%
+6,401
New +$57.9K
FSI icon
704
Flexible Solutions
FSI
$63.9M
$62K ﹤0.01%
+15,124
New +$55K
CYPH
705
Cypherpunk Technologies Inc
CYPH
$66.2M
$61K ﹤0.01%
3,470
-2,160
-38% -$46.2K
DBTX
706
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$60K ﹤0.01%
+19,700
New +$75.5K
CLSD
707
DELISTED
Clearside Biomedical
CLSD
$59K ﹤0.01%
+1,707
New +$51.1K
ELEV
708
DELISTED
Elevation Oncology
ELEV
$59K ﹤0.01%
+23,500
New +$94.2K
PVLA
709
Palvella Therapeutics
PVLA
$1.98B
$59K ﹤0.01%
+245
New +$64.4K
SGRP
710
DELISTED
SPAR Group
SGRP
$58K ﹤0.01%
+44,300
New +$56K
URG
711
Ur-Energy
URG
$485M
$58K ﹤0.01%
+36,200
New +$51.2K
CALA
712
DELISTED
Calithera Biosciences, Inc
CALA
$49K ﹤0.01%
+6,114
New +$62.5K
BWEN icon
713
Broadwind
BWEN
$113M
$39K ﹤0.01%
+18,000
New +$35K
CASI
714
DELISTED
CASI Pharmaceuticals
CASI
$20K ﹤0.01%
+2,510
New +$19.7K
NERV icon
715
Minerva Neurosciences
NERV
$188M
$20K ﹤0.01%
+3,050
New +$18.7K
ABCB icon
716
Ameris Bancorp
ABCB
$5.9B
-5,211
Closed -$259K
ADEA icon
717
Adeia
ADEA
$2.86B
-45,738
Closed -$229K
AKAM icon
718
Akamai
AKAM
$16.8B
-42,829
Closed -$5.01M
ALGN icon
719
Align Technology
ALGN
$12B
-376
Closed -$247K
ALTG icon
720
Alta Equipment Group
ALTG
$210M
-16,874
Closed -$247K
AMN icon
721
AMN Healthcare
AMN
$1.28B
-2,730
Closed -$334K
ANGO icon
722
AngioDynamics
ANGO
$562M
-9,600
Closed -$265K
APH icon
723
Amphenol
APH
$188B
-4,980
Closed -$218K
ASO icon
724
Academy Sports + Outdoors
ASO
$2.89B
-16,900
Closed -$742K
ATRA icon
725
Atara Biotherapeutics
ATRA
$71.2M
-602
Closed -$237K

Similar funds

Bailard's Q1 2022 Portfolio in Review

As of Q1 2022, Bailard held 836 positions worth $2.97B, down 5.2% from $3.14B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bailard's Q1 2022 filing shows 124 new, 242 increased, 227 reduced and 121 closed positions. Its largest new stake was iShares MSCI Intl Quality Factor ETF: 107,344 shares worth $3.96M. The largest sale was iShares Russell 2000 Value ETF, an estimated $80.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q1 2022 buy was iShares MSCI Intl Quality Factor ETF: 107,344 shares worth $3.96M.
  • Bailard added most to SPDR Gold Trust in Q1 2022, an estimated $76.8M increase.
  • Bailard's biggest Q1 2022 reduction was iShares Russell 2000 Value ETF, cutting an estimated $80.2M.
  • Bailard fully exited Akamai in Q1 2022, selling an estimated $5.01M.
  • Bailard's ten largest holdings make up 31% of its $2.97B portfolio in Q1 2022.
  • Bailard opened 124 new positions and closed 121 in Q1 2022.
  • Bailard's portfolio value fell 5.2% quarter-over-quarter to $2.97B.

Based on Bailard's 13F filing for Q1 2022, filed 25 Apr 2022.